All Stories

  1. Brain Volume Changes After Targeted Closure of Spinal CSF Leak in Spontaneous Intracranial Hypotension
  2. Silent brain infarct in migraine: Systematic review and meta-analysis
  3. A technique to localize posteriorly located spinal dural leaks associated with spontaneous intracranial hypotension: Dorsal-decubitus dynamic CT myelography
  4. Pathogenic SCN2A variants are associated with familial and sporadic hemiplegic migraine
  5. Case report: Meningitis: a cause of reversible cerebral vasoconstriction syndrome?
  6. Reversible cerebral Vasoconstriction syndrome intERnational CollaborativE (REVERCE) network: Study protocol and rationale of a multicentre research collaboration
  7. Complications of reversible cerebral vasoconstriction syndrome in relation to age
  8. Genetics of migraine: where are we now?
  9. Outcomes among patients with primary angiitis of the CNS: A Nationwide United States analysis
  10. European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure
  11. The teaching of headache medicine in France: A questionnaire‐based study
  12. Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data
  13. Diagnostic utility of T2*-weighted GRE in migraine with aura attack. The cortical veins sign
  14. Systematic Review and Meta-analysis of Acute Treatments for Episodic Migraine in Adults
  15. Hemiplegic Migraine Associated With PRRT2 Variations
  16. Outcomes Among Patients With Reversible Cerebral Vasoconstriction Syndrome: A Nationwide United States Analysis
  17. Genetics of migraine
  18. Revised guidelines of the French Headache Society for the diagnosis and management of migraine in adults. Part 1: Diagnosis and assessment
  19. Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 2: Pharmacological treatment
  20. Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 3: Non-pharmacological treatment
  21. Foreword
  22. Type of headache at onset and risk for complications in reversible cerebral vasoconstriction syndrome
  23. Diagnosis and management of migraine in ten steps
  24. Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance
  25. Burden and Attitude to Resistant and Refractory Migraine A Survey From the European Headache Federation With the Endorsement of the European Migraine & Headache Alliance
  26. Severe migraine and its control: A proposal for definitions and consequences for care
  27. Mechanical Thrombectomy in Nighttime Hours: Is There a Difference in 90-Day Clinical Outcome for Patients with Ischemic Stroke?
  28. Oral steroids for episodic cluster headache
  29. Circulating microRNAs Associated With Reversible Cerebral Vasoconstriction Syndrome
  30. Acute retinal arterial ischaemia: silent brain infarcts prevalence and short‐term recurrence
  31. European headache federation consensus on the definition of resistant and refractory migraine
  32. Long-Term Outcomes After Reversible Cerebral Vasoconstriction Syndrome
  33. Concomitant reversible cerebral vasoconstriction syndrome and transient global amnesia
  34. A Clinico-Radiological Study of Cerebral Amyloid Angiopathy-Related Inflammation
  35. Reversible giant arachnoid granulations
  36. Primary angiitis of the CNS and reversible cerebral vasoconstriction syndrome
  37. Recommandations pour le diagnostic et la prise en charge de la névralgie trigéminale classique
  38. Migraine with brainstem aura: Why not a cortical origin?
  39. French guidelines for diagnosis and treatment of classical trigeminal neuralgia (French Headache Society and French Neurosurgical Society)
  40. Reversible Cerebral Vasoconstriction Syndrome Without Typical Thunderclap Headache
  41. The Link Between Migraine, Reversible Cerebral Vasoconstriction Syndrome and Cervical Artery Dissection
  42. The Typical Thunderclap Headache of Reversible Cerebral Vasoconstriction Syndrome and its Various Triggers
  43. Occipital neuralgia heralding occipital condyle syndrome revealing vesical leiomyosarcoma skull base metastasis
  44. Recurrence of Migraine With Aura After a 24-year Free Period Following rTMS Treatment for Fibromyalgia Pain
  45. Headache arising from idiopathic changes in CSF pressure
  46. Are migraineurs naturally born “well-hearted”?
  47. Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection
  48. RCVS and CVT
  49. Comment: Reversible cerebral vasoconstriction syndrome can hit twice
  50. La migraine joue-t-elle sur les vaisseaux ?
  51. Génétique des céphalées1
  52. Ischaemic Strokes with Reversible Vasoconstriction and without Thunderclap Headache: A Variant of the Reversible Cerebral Vasoconstriction Syndrome?
  53. Sindrome di vasocostrizione cerebrale reversibile
  54. Recommandations pour le diagnostic et le traitement de l’algie vasculaire de la face
  55. La vasodilatation a-t-elle un rôle dans la migraine ? Commentaires
  56. Le syndrome post-ponction lombaire. Revue de la littérature et expérience des urgences céphalées
  57. Reversible cerebral vasoconstriction syndrome and treatment with monoamine oxidase inhibitor
  58. Carotid paraganglioma mimicking a cluster headache
  59. Familial hemiplegic migraine: A model for the genetic studies of migraine
  60. Phénotypes de l’aura migraineuse
  61. Céphalée du naufrage, une entité absente de la nouvelle classification ICHD-3
  62. Reversible Cerebral Vasoconstriction Syndrome
  63. Subarachnoid and intra-cerebral hemorrhage in young adults: Rare and underdiagnosed
  64. Reversible cerebral vasoconstriction syndrome
  65. Physiopathologie et génétique de la migraine
  66. Reversible cerebral vasoconstriction syndrome and cervical artery dissection in 20 patients
  67. The International Classification of Headache Disorders, 3rd edition (beta version)
  68. Génétique de la migraine
  69. L37. Reversible cerebral vasoconstriction syndrome: Distinction from CNS vasculitis
  70. Nouvelle approche pharmacologique des traitements de fond
  71. Occipital Injections for Trigemino-Autonomic Cephalalgias: Evidence and Uncertainties
  72. Migraine et céphalée de tension : ce que doit connaître le rhumatologue
  73. CERVCO, Centre de référence des maladies vasculaires rares du cerveau et de l’oeil
  74. Thunderclap headache
  75. Migraine, Genetics
  76. Use of cannabis among 139 cluster headache sufferers
  77. Reversible cerebral vasoconstriction syndrome
  78. Emotional Status, Perceived Control of Pain, and Pain Coping Strategies in Episodic and Chronic Cluster Headache
  79. Anne Ducros
  80. Suboccipital steroid injections for transitional treatment of patients with more than two cluster headache attacks per day: a randomised, double-blind, placebo-controlled trial
  81. Use of Antimigraine Treatments by General Practitioners
  82. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management
  83. Headache Attributed to Giant Cell (Temporal) Arteritis
  84. Reversible Cerebral Vasoconstriction Syndromes
  85. Acute Headache in the Emergency Department
  86. Hemorrhagic Manifestations of Reversible Cerebral Vasoconstriction Syndrome
  87. De novo mutations in ATP1A2 and CACNA1A are frequent in early-onset sporadic hemiplegic migraine
  88. Génétique de la migraine
  89. Reversible cerebral vasoconstriction syndrome in two patients with a carotid glomus tumour
  90. Le syndrome de vasoconstriction cérébrale réversible
  91. Syndrome de vasoconstriction cérébrale réversible
  92. Acute headache in the emergency department
  93. Reversible cerebral vasoconstriction syndrome
  94. Génétique des céphalées
  95. Emergency Treatment of Migraine
  96. Postpartum Cervicocephalic Artery Dissection
  97. Migraine hémiplégique familiale et sporadique
  98. Cluster headache
  99. Aspects cliniques et radiologiques du syndrome de vasoconstriction cérébrale réversible. Une série prospective de 67 patients
  100. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients
  101. Most Cases Labeled as ???Retinal Migraine??? Are Not Migraine
  102. Hemiplegic Migraine: Clinical Features, Links with Basilar-type Migraine, Current and Future Treatment
  103. Late-onset eosinophilic chronic meningitis occurring 30 years after Taenia solium infestation in a white Caucasian woman
  104. Chronic Paroxysmal Hemicrania in a Patient with a Macroprolactinoma
  105. Physiopathologie et approche g??n??tique de la migraine
  106. Migraine
  107. Treating Depression in Children and Adolescents
  108. ATP1A2 mutations in 11 families with familial hemiplegic migraine
  109. A Negative D-Dimer Assay Does Not Rule Out Cerebral Venous Thrombosis: A Series of Seventy-Three Patients
  110. Céphalées en coup de tonnerre
  111. Démarche diagnostique et thérapeutique dans 40 cas d’hypotension intracrânienne spontanée
  112. Early epidural blood patch in spontaneous intracranial hypotension
  113. Migraine hémiplégique familiale
  114. Migraine ophtalmique ou migraine avec aura visuelle
  115. Familial Cluster Headache: A Series of 186 Index Patients
  116. The Genetics of Migraine
  117. Absence of linkage to 8q24 in a European family with familial adult myoclonic epilepsy (FAME)
  118. Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis
  119. The Clinical Spectrum of Familial Hemiplegic Migraine Associated with Mutations in a Neuronal Calcium Channel
  120. Sporadic late onset paroxysmal cerebellar ataxia in four unrelated patients: a new disease?
  121. Missense CACNA1A Mutation Causing Episodic Ataxia Type 2
  122. Mutations de CACNA1A et migraine hémiplégique familiale.
  123. Genetics of familial hemiplegic migraine
  124. CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy
  125. Decreased hemispheric water mobility in hemiplegic migraine related to mutation of CACNA1A gene
  126. Migraine and ataxias
  127. Recurrent Episodes of Coma: An Unusual Phenotype of Familial Hemiplegic Migraine with Linkage to Chromosome 1
  128. High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2
  129. Recurrence of the T666M Calcium Channel CACNA1A Gene Mutation in Familial Hemiplegic Migraine with Progressive Cerebellar Ataxia
  130. Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity
  131. Notch3 Mutations in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), a Mendelian Condition Causing Stroke and Vascular Dementia
  132. HEREDITARY PAROXYSMAL ATAXIAS
  133. A Human Homolog of Bacterial Acetolactate Synthase Genes Maps within the CADASIL Critical Region
  134. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia
  135. Monozygotic twins discordant for familial hemiplegic migraine
  136. A gene for hereditary paroxysmal cerebellar ataxia maps to chromosome 19p
  137. Migraine, Genetics
  138. Emotional Status, Perceived Control of Pain, and Pain Coping Strategies in Episodic and Chronic Cluster Headache